Trius Therapeutics initiates phase 3 clinical trial of oral torezolid phosphate for treatment of ABS
The double-blind, active control, pivotal study is design...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
